NVDA: US Lifts China Export Restrictions; 25% Revenue Upside Potential
Social media chatter claims the US approved Chinese companies to buy NVIDIA chips, lifting all export restrictions and trading bans. If verified, China represented 25% of NVIDIA's revenue pre-restriction; restoration could trigger significant upside. Clarity on scope and timing remains critical, and official confirmation is pending.
RKey facts
- Social media claims US lifted China export restrictions on NVIDIA chips and all trading bans
- China historically represented 25% of NVIDIA's pre-restriction revenue
- NVIDIA shares already rallied on AI infrastructure demand; additional upside priced in if claim verified
- No official confirmation from US government or NVIDIA included in batch; unverified claim
What's happening
A widely-circulated claim on X and trading forums states that the US just approved Chinese companies to buy NVIDIA chips, lifting all export restrictions and trading bans. The alleged implication is that China, which historically accounted for 25% of NVIDIA's total revenue before restrictions were imposed, could represent a major revenue restoration catalyst. NVIDIA shares have already moved higher this week, and this narrative is fueling further momentumThe empirical fact that winners keep winning over the medium term. in semiconductor and AI infrastructure trades.
However, critical details are missing from the batch. No official statement from the US government, the Commerce Department, or NVIDIA has been included to verify the claim. Similarly, there is no clarity on whether the alleged lifting applies only to certain chip classes (e.g., inference-focused H-series) or all products. NVIDIA CEO Jensen Huang has previously noted that China represents both growth opportunity and geopolitical risk, and any policy shift would likely come with conditions or phase-ins rather than blanket removal of restrictions.
The narrative is gaining traction in social trading communities and meme-stock style chatter, partly because the upside math is compelling: 25% of NVIDIA's revenue represents roughly $18 to $20 billion in annual sales, depending on the fiscal year. Restoration of that revenue stream would materially expand NVIDIA's earnings and justify higher valuation multiples. However, such a dramatic reversal of longstanding Trump-era technology export policy would be unprecedented and warrant official confirmation.
A skeptical read suggests this is rumor-driven momentumThe empirical fact that winners keep winning over the medium term. rather than policy fact. NVIDIA is already near all-time highs, and sentiment is extremely bullish; confirmation bias may be inflating minor policy signals into a false narrative. Traders should await official statements from the US Commerce Department or NVIDIA before positioning heavily on this claim.
What to watch next
- 01Official US Commerce Department or State Department statement on China chip policy: urgent
- 02NVIDIA investor call comments on China strategy: next earnings
- 03Competitive response from AMD, Intel, TSMC: ongoing
- PR Newswire FinancialEightco Holdings (NASDAQ: ORBS) dichiara un portafoglio complessivo di circa 340 milioni di dollari, che comprende OpenAI, Beast Industries, oltre 11.000 ETH e più di 283 milioni di token WLD
Composizione della tesoreria di Eightco al 12 maggio 2026: 90 milioni di dollari in azioni OpenAI (indirette), 18 milioni di dollari in azioni Beast Industries, 11.068 ETH, 283 milioni di WLD e 129 milioni di dollari in contanti e mezzi equivalenti, per un totale di circa 340 milioni di...
1h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Willis Towers Watson plc - WTW
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Willis Towers Watson plc ("Willis Towers Watson" or the "Company") (NASDAQ: WTW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Blaize Holdings, Inc. - BZAI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Blaize Holdings, Inc. ("Blaize" or the "Company") (NASDAQ: BZAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Corporation - MRBK
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Meridian Corporation ("Meridian" or the "Company") (NASDAQ: MRBK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of JetBlue Airways Corporation - JBLU
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of JetBlue Airways Corporation ("JetBlue" or the "Company") (NASDAQ: JBLU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Compass Therapeutics, Inc. ("Compass" or the "Company") (NASDAQ: CMPX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sportradar Group AG - SRAD
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sportradar Group AG ("Sportradar" or the "Company") (NASDAQ: SRAD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Grace Therapeutics, Inc. - GRCE
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Grace Therapeutics, Inc. ("Grace" or the "Company") (NASDAQ: GRCE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
4h ago
Related coverage
- NVDA Surges as US Lifts China Export Restrictions; 25% Revenue UnlockedTech & AI··0 mentions
- U.S. Lifts NVIDIA China Restrictions, Restoring 25% of Revenue PipelineTech & AI··0 mentions
- US Approves NVIDIA H200 Exports to China; AI Capex Cycle BroadensTech & AI··0 mentions
- U.S. Approves NVDA H200 Sales to 10 Chinese Firms Amid Trump-Xi SummitTech & AI··0 mentions
More about $NVDA
- S&P 500 AI Concentration Peaks; Active Managers Lag as Mega-Cap Dominance Persists·Equities US
- NVDA Surges as US Lifts China Export Restrictions; 25% Revenue Unlocked·Tech & AI
- S&P 500 and Nasdaq Hit Records While Breadth Stalls: AI Mega-Caps Carry Market, Active Managers Lag·Equities US
- AI Buildout Spreading Beyond Chips Into Networking, Robotics, and Data Centers: Cisco, Meta Deals Signal Capex Acceleration·Tech & AI
- Trump-Xi Beijing Summit Drives Trade Truce Optimism: Agricultural, Oil, and Tech Negotiations In Play·Equities US
Live coverage of the AI semiconductor cycle — NVDA, AVGO, AMD, ASML, memory demand, capex run rates and overbought signals.